Kohen Avocats · Paris law firm
—

Maître Hassan KOHEN assists English-speaking clients throughout France, including in urgent proceedings. Initial strategic review: €80 incl. VAT, personal reply within 24 hours.

100% confidential · Attorney-client privilege · No commitment

Paris Bar Urgent defence & litigation Official CNB profile (avocat.fr)
Maître Hassan Kohen, avocat en droit des étrangers à Paris
Maître Hassan KOHEN
Attorney · Paris Bar

The Medical Residence Permit in France (Étranger Malade): A Practical Guide to Article L. 425-9 of the CESEDA

Speak with a lawyer 06 89 11 34 45

Foreign nationals residing in France who suffer from a serious medical condition may be eligible for a specific type of residence permit: the titre de séjour pour étranger malade (medical residence permit), governed by Article L. 425-9 of the Code de l’entrée et du séjour des étrangers et du droit d’asile (CESEDA). This pathway, distinct from employment-based or family-based immigration, allows individuals whose health would be gravely endangered by a return to their country of origin to obtain temporary legal residence in France for medical treatment. For English-speaking expatriates, their family members, and employers seeking to understand the rights of foreign workers facing health crises, the étranger malade procedure is a critical safeguard, but also one of the most procedurally complex areas of French immigration law.

This article examines the legal conditions, the role of the Office français de l’immigration et de l’intégration (OFII) medical board, the most common grounds for refusal, and the judicial remedies available when a prefecture denies or withdraws a medical residence permit.

I. The Legal Framework: Conditions for Obtaining a Medical Residence Permit

A. The Three Cumulative Conditions Under Article L. 425-9

Article L. 425-9 of the CESEDA, in its version currently in force, sets out three cumulative conditions that must all be satisfied for a foreign national to qualify for a medical residence permit. The provision reads as follows:

« L’étranger, résidant habituellement en France, dont l’état de santé nécessite une prise en charge médicale dont le défaut pourrait avoir pour lui des conséquences d’une exceptionnelle gravité et qui, eu égard à l’offre de soins et aux caractéristiques du système de santé dans le pays dont il est originaire, ne pourrait pas y bénéficier effectivement d’un traitement approprié, se voit délivrer une carte de séjour temporaire portant la mention « vie privée et familiale » d’une durée d’un an. »

>

(Art. L. 425-9 CESEDA)

Translated: the foreign national who habitually resides in France, whose state of health requires medical care the absence of which could have consequences of exceptional gravity, and who, taking into account the healthcare available and the characteristics of the healthcare system in their country of origin, could not effectively receive appropriate treatment there, shall be issued a one-year temporary residence permit bearing the designation « vie privée et familiale » (private and family life).

First condition: habitual residence in France. The applicant must demonstrate that they ordinarily live in France. While the CESEDA does not specify a minimum period of residence, administrative practice and case law require that France be the applicant’s primary and stable place of living. Tourists or short-term visitors do not qualify; the applicant must be physically present on French territory and establish that they have made France their centre of life.

Second condition: consequences of exceptional gravity in the absence of treatment. This is the most demanding of the three conditions. The Administrative Court of Appeal of Nancy, in a detailed decision of 19 December 2023, clarified the definition of « conséquences d’une exceptionnelle gravité » by reference to Article 4 of the Order of 5 January 2017, which sets out the general guidelines for OFII medical assessments:

« Cette condition des conséquences d’une exceptionnelle gravité résultant d’un défaut de prise en charge doit être regardée comme remplie chaque fois que l’état de santé de l’étranger concerné présente, en l’absence de la prise en charge médicale que son état de santé requiert, une probabilité élevée à un horizon temporel qui ne saurait être trop éloigné de mise en jeu du pronostic vital, d’une atteinte à son intégrité physique ou d’une altération significative d’une fonction importante. »

>

(CAA Nancy, 5ème ch., 19 Dec. 2023, n° 23NC00427, citing art. 4 of the Order of 5 January 2017)

This means the condition is satisfied whenever the applicant’s health, without the required medical care, presents a high probability, within a reasonably foreseeable timeframe, of: (a) a threat to the vital prognosis (risk of death), (b) harm to physical integrity, or (c) a significant deterioration of an important bodily function. The court further specified that when the exceptional gravity is likely to occur only in the medium term with high probability, such as in the case of progressive chronic diseases, the assessment must take into account the consequences of interrupting the treatment currently received in France, i.e. the rupture of continuity of care.

Third condition: impossibility of effective access to appropriate treatment in the country of origin. Even if the condition is serious, the residence permit will be refused if appropriate treatment is actually available and accessible to the applicant in their country of origin. The Administrative Court of Appeal of Bordeaux, in a significant ruling of 12 February 2026, articulated the standard as follows:

« Pour déterminer si un étranger peut bénéficier effectivement dans le pays dont il est originaire d’un traitement médical approprié, au sens des dispositions précitées, il convient de s’assurer, eu égard à la pathologie de l’intéressé, de l’existence d’un traitement approprié et de sa disponibilité dans des conditions permettant d’y avoir accès, et non de rechercher si les soins dans le pays d’origine sont équivalents à ceux offerts en France ou en Europe. »

>

(CAA Bordeaux, 1ère ch., 12 Feb. 2026, n° 25BX01405)

The test is therefore twofold: first, does an appropriate treatment exist for the specific pathology? Second, is it available under conditions that allow the applicant to actually access it? The standard is not one of equivalence with French or European standards of care; rather, it is one of effective availability, taking into account the applicant’s personal circumstances, including the cost of treatment, the existence of adequate healthcare infrastructure, and whether the treatment is genuinely accessible to the general population.

Where the treatment exists but the applicant argues they cannot access it — either because it is not accessible to the general population due to cost or lack of adapted care structures, or because exceptional circumstances specific to their personal situation would prevent access — the administrative authority must, on the basis of all available information, assess whether the applicant can effectively benefit from appropriate treatment.

B. The OFII Medical Board: Role, Composition, and Procedure

The administrative decision to grant or refuse a medical residence permit is not made by the prefecture alone. Article L. 425-9 requires that the prefecture first obtain a prior medical opinion from a collège de médecins (panel of physicians) of the OFII medical service. This opinion is governed by the Order of 27 December 2016, which specifies the procedure in detail.

The OFII medical board is composed of three physicians designated for each case. They issue their opinion on the basis of a medical report prepared by a separate OFII physician — the médecin rapporteur — who must not sit on the board for the same case. The Administrative Court of Appeal of Paris confirmed the regularity of this procedure in a decision of 3 October 2023, noting that the medical report must be established and transmitted to the board by a physician distinct from the three board members:

« il ressort du bordereau de transmission de cet avis que le rapport médical, produit en appel par l’OFII, a été établi et transmis au collège de médecins de l’OFII le 1er octobre 2021 par le docteur F… D…, qui ne figurait pas parmi les membres du collège des médecins. »

>

(CAA Paris, 6ème ch., 3 Oct. 2023, n° 22PA03700)

The medical board’s opinion must address four points, as set out in Article 6 of the Order of 27 December 2016: (a) whether the applicant’s state of health requires medical care; (b) whether the absence of such care would or would not entail consequences of exceptional gravity; (c) whether, in light of the healthcare available and the characteristics of the healthcare system in the country of origin, the applicant could or could not effectively receive appropriate treatment there; and (d) the foreseeable duration of the treatment.

A critical procedural point is that the board is not required to assess the availability of treatment in the country of origin (point c) if it has already concluded that the absence of care would not entail consequences of exceptional gravity (point b). As the CAA Nancy held in its 19 December 2023 decision: if the board finds that the condition is not of exceptional gravity, it has no obligation to examine the healthcare situation in the country of origin.

Moreover, as established by the same Paris decision, French law does not impose an obligation on the administration to communicate the medical report to the applicant before issuing a refusal:

« aucune des dispositions précitées, ni aucune autre disposition, n’impose la communication du rapport médical au demandeur d’un titre de séjour en qualité d’étranger malade préalablement à l’édiction d’une décision lui refusant son titre. »

>

(CAA Paris, n° 22PA03700, ibid.)

However, the applicant may request the communication of the full medical file in the context of subsequent litigation, as discussed in Part II below.

Special motivation requirement. Article L. 425-9 contains an important safeguard: if the OFII medical board issues a favourable opinion, concluding that the statutory conditions are met, the prefecture may only refuse the permit by a decision that is spécialement motivée (specially reasoned). This means the prefecture cannot simply disregard a favourable medical opinion without providing specific, detailed reasons for doing so — a higher standard than ordinary administrative motivation.

II. Practical Issues: Refusals, Renewals, and Judicial Remedies

A. Common Grounds for Refusal and Prefecture Errors

Prefectures refuse medical residence permits on several recurring grounds, many of which reveal procedural errors that can form the basis for a successful legal challenge.

The prefecture considers itself bound by the OFII opinion. A particularly frequent error occurs when the prefecture treats the OFII medical board’s opinion as binding. French administrative case law consistently holds that the prefecture retains its own discretionary power of assessment and must not consider itself in a situation of compétence liée (bound competence) vis-à-vis the OFII opinion. The CAA Paris, in its October 2023 decision, examined and rejected an argument that the prefect had improperly considered himself bound by the medical board’s opinion, finding instead that he had appropriated its reasoning and exercised independent judgment.

When the prefecture merely reproduces the terms of the medical opinion without demonstrating that it has conducted its own particular examination of the applicant’s individual situation, the decision may be annulled for erreur de droit (error of law). Conversely, if the prefecture does appropriate the board’s reasoning and exercises independent scrutiny, the decision will withstand challenge on this ground.

Insufficient evidence of exceptional gravity. A second common refusal ground is the insufficiency of medical certificates provided by the applicant. The CAA Nancy, in its December 2023 decision, rejected a challenge where the applicant produced only a single psychiatric certificate dated more than one year before the prefectural decision and failed to produce any more recent medical evidence showing that his condition continued to require treatment whose absence would have consequences of exceptional gravity. The court emphasised that the applicant must provide contemporaneous, detailed, and specific medical evidence; general statements by physicians without precise clinical detail will not suffice to contradict the OFII opinion.

Treatment availability in the country of origin. The most fact-intensive disputes concern the third condition: whether appropriate treatment is effectively available in the applicant’s country of origin. The CAA Versailles, in a decision of 13 November 2025, upheld a prefectural refusal where the applicant, a Togolese national suffering from a cardiac condition, argued that his medication was unavailable in Togo. The court examined the OFII’s evidence showing that cardiology specialist follow-up was available at the university hospital of Lomé and that all molecules in his treatment regimen were either available in Togo or could be substituted with equivalent molecules from the same therapeutic class:

« il ressort des pièces produites par l’OFII que le suivi spécialisé en cardiologie est disponible au centre hospitalier universitaire de Lomé, et que l’ensemble des molécules composant le traitement médicamenteux pris par M. A… sont disponibles au Togo, ou peuvent être substituées par des molécules de la même classe thérapeutique qui y sont disponibles. »

>

(CAA Versailles, 5ème ch., 13 Nov. 2025, n° 25VE02486)

This illustrates the importance of producing detailed and specific medical evidence tailored to the availability of the exact treatment required. General references to the weakness of the healthcare system in the country of origin, unsupported by specific information about the availability of the particular treatment needed, will rarely suffice to overturn a refusal.

Renewal refusals. The renewal of a medical residence permit is not automatic. Under Article L. 613-1 of the CESEDA, the renewal may be refused if the foreign national ceases to fulfil one of the conditions required for the issuance of the card. The CAA Douai, in a decision of 10 April 2025, upheld a renewal refusal where the OFII board had found, at the time of renewal, that the applicant’s condition, while still requiring care, no longer met the threshold of exceptional gravity:

« Il ressort des termes de la décision litigieuse portant refus de renouvellement de titre de séjour que celle-ci, qui vise et cite notamment l’article L. 425-9 du code de l’entrée et du séjour des étrangers et du droit d’asile »

>

(CAA Douai, 1ère ch., 10 Apr. 2025, n° 24DA00644)

The renewal assessment is a fresh, full examination of the applicant’s medical situation at the time of renewal, not merely a continuation of the previous grant. The applicant must demonstrate that the condition still meets all three Article L. 425-9 requirements as of the renewal date.

B. Judicial Review: Challenging a Refusal Before the French Administrative Courts

Jurisdiction and time limits. A refusal of a medical residence permit, whether an initial application or a renewal, together with any accompanying OQTF (order to leave French territory), may be challenged before the tribunal administratif (administrative court) of the applicant’s place of residence. The standard time limit for bringing an excès de pouvoir (abuse of power) challenge is two months from notification of the decision. If the decision is accompanied by an OQTF with a 30-day voluntary departure period, the time limit for challenging the OQTF is reduced to 30 days. In the case of an OQTF without a voluntary departure period, the challenge period is 48 hours.

The burden of proof and the shifting evidentiary framework. The most significant jurisprudential development in recent years concerns the allocation of the evidentiary burden in medical residence permit litigation. The CAA Bordeaux, in its landmark decision of 12 February 2026, established a clear burden-shifting framework:

« La partie qui justifie d’un avis du collège de médecins du service médical de l’Office français de l’immigration et de l’intégration (OFII) qui lui est favorable doit être regardée comme apportant des éléments de fait susceptibles de faire présumer l’existence ou l’absence d’un état de santé de nature à justifier la délivrance ou le refus d’un titre de séjour. Dans ce cas, il appartient à l’autre partie, dans le respect des règles relatives au secret médical, de produire tous éléments permettant d’apprécier l’état de santé de l’étranger et, le cas échéant, l’accès effectif ou non à un traitement approprié dans le pays de renvoi. »

>

(CAA Bordeaux, n° 25BX01405, ibid.)

Translated: the party that produces a favourable OFII medical board opinion is deemed to have presented factual elements raising a presumption of the existence or absence of a medical condition justifying the grant or refusal of a residence permit. In such cases, the burden shifts to the opposing party — whether the prefecture or the applicant — to produce all available evidence, respecting medical confidentiality, to enable the court to assess the applicant’s state of health and, where applicable, effective access to treatment in the country of return.

This framework has profound practical implications. If the OFII opinion is favourable to the applicant, it falls on the prefecture to rebut the presumption by producing evidence that appropriate treatment is available. If the OFII opinion is unfavourable, the applicant must produce sufficiently detailed medical certificates and country-condition evidence to reverse the presumption.

In the Bordeaux case itself, the applicant — a Nigerian national suffering from schizophrenia and post-traumatic stress disorder — successfully reversed the unfavourable OFII presumption by producing detailed psychiatric certificates demonstrating: (a) that her condition had not improved; (b) that she had been granted the medical residence permit twice previously on the basis of the same condition; (c) that her treatment involved antipsychotic medications at maximum dosage that were not available or substitutable in Nigeria; and (d) that discontinuing treatment could lead to auto- or hetero-aggressive consequences of an unpredictable nature. The court also noted that the prefecture had merely asserted, without justification, that its assessment was based on a generic « analysis of the existence and accessibility of care in the country of origin by expert physicians. »

The role of medical confidentiality and the L. 425-9-1 procedure. A procedural innovation introduced to strengthen judicial review is found in Article L. 425-9-1 of the CESEDA. When the administrative court is seized of a challenge relating to the applicant’s state of health, it may call upon the OFII to present observations, which may include any information covered by medical confidentiality (Article L. 1110-4 of the Public Health Code) relevant to the decision. As cited by the CAA Versailles in its November 2025 decision:

« Lorsque le juge administratif saisi, à l’appui de conclusions tendant à l’annulation d’une décision de refus du titre de séjour mentionné au premier alinéa de l’article L. 425-9, d’un moyen relatif à l’état de santé du demandeur, appelle l’Office français de l’immigration et de l’intégration à présenter des observations, celles-ci peuvent comporter toute information couverte par l’article L. 1110-4 du code de la santé publique en lien avec cette décision. »

>

(CAA Versailles, n° 25VE02486, ibid.)

This mechanism allows the judge to obtain the full OFII medical file — including the rapporteur’s report that formed the basis of the board’s opinion — directly from the OFII, within the framework of the proceedings and subject to the adversarial principle. The applicant must, however, first waive medical confidentiality by raising a plea relating to their state of health; it is then for the court to decide whether to call for OFII observations.

Protection against removal. A medical residence permit holder, or an applicant who satisfies the L. 425-9 conditions, enjoys protection against removal under Article L. 611-3, 9° of the CESEDA, which provides that a foreign national habitually residing in France whose state of health requires medical care, the absence of which could have consequences of exceptional gravity, and who could not effectively receive appropriate treatment in the country of removal, may not be made subject to an OQTF.

The standard for evaluating the healthcare system in the country of origin. The assessment of whether treatment is available and accessible in the applicant’s country of origin must be conducted on the basis of specific, objective criteria. As defined by Article 3 of the Order of 5 January 2017 — cited and applied by the Administrative Court of Appeal of Lyon in a decision of 20 January 2026 — the evaluation of the healthcare supply in the country of origin is carried out as follows:

« L’offre de soins s’apprécie notamment au regard de l’existence de structures, d’équipements, de médicaments et de dispositifs médicaux, ainsi que de personnels compétents nécessaires pour assurer une prise en charge appropriée de l’affection en cause. L’appréciation des caractéristiques du système de santé doit permettre de déterminer la possibilité ou non d’accéder effectivement à l’offre de soins et donc au traitement approprié. »

>

(CAA Lyon, 1ère ch., 20 Jan. 2026, n° 25LY00815)

This means that the analysis must go beyond the mere theoretical existence of a medication or treatment protocol. It must examine whether the healthcare infrastructure — hospitals, equipment, trained personnel — is sufficient to deliver the treatment, and whether the applicant can realistically access it given their personal circumstances, including financial means and the functioning of the healthcare system as a whole.

What the court can order. If the administrative court annuls the refusal, it may issue an injunction to the prefecture. The most common remedy is an order to réexaminer (re-examine) the application within a specified period, often one to two months, with an order to issue a provisional residence authorisation (autorisation provisoire de séjour) in the interim. In stronger cases, particularly where the applicant has previously held the permit and the conditions are clearly met, the court may directly order the prefecture to issue the residence permit. The CAA Bordeaux, in its February 2026 decision, ordered the prefecture to issue a one-year vie privée et familiale residence permit within two months, noting that the case did not warrant a multi-year card.

Practical guidance for applicants. Based on the case law surveyed above, several practical points emerge for applicants and their counsel:

First, the quality of the medical evidence is decisive. Certificates must be recent, detailed, and specifically address each of the three L. 425-9 conditions. A general statement that the patient « requires treatment » is insufficient; the certificate should explain the diagnosis, the treatment protocol, why discontinuation would have consequences of exceptional gravity (with reference to the precise criteria: vital prognosis, physical integrity, or significant functional impairment), and — crucially — why the specific treatment is not available or accessible in the country of origin.

Second, the applicant should request communication of the OFII medical file as soon as litigation is initiated. Although the administration is not required to provide the rapporteur’s report before issuing its decision, the adversarial principle entitles the applicant to access it during proceedings, enabling a targeted challenge to the medical board’s findings.

Third, where the OFII opinion is unfavourable, the applicant must produce evidence that not only addresses their medical condition but also rebuts the specific findings of the board. Generic evidence about the weakness of the healthcare system in the country of origin is unlikely to succeed; the evidence must demonstrate the unavailability or inaccessibility of the specific treatment required.

Fourth, the spécialement motivée requirement in the case of a favourable OFII opinion provides a distinct ground for annulment: if the prefecture disregards a favourable medical opinion without detailed, specific reasoning, the decision is vulnerable to challenge on motivation grounds alone.

For more information on residence permit procedures and appeals in the French immigration system, see our guide to immigration law in France.

Conclusion

The étranger malade medical residence permit under Article L. 425-9 of the CESEDA represents a vital protection for foreign nationals whose health would be seriously endangered by removal from France. The procedure is rigorous: it requires the applicant to satisfy three cumulative conditions through detailed medical evidence, to navigate the OFII medical board procedure, and, in the event of refusal, to mount a well-documented challenge before the administrative courts within strict time limits.

The jurisprudence of the administrative courts of appeal over the past three years has clarified key aspects of the regime: the definition of exceptional gravity (CAA Nancy, 2023), the independence of the prefecture’s assessment from the OFII opinion (CAA Paris, 2023), the standard for evaluating treatment availability (CAA Versailles, 2025), and the shifting evidentiary framework that allocates the burden of proof between the parties (CAA Bordeaux, 2026). Taken together, these decisions provide a coherent and increasingly predictable framework for applicants and their legal counsel.

Success in this area depends on meticulous preparation of medical evidence, a thorough understanding of the procedural requirements governing the OFII medical board, and, where necessary, prompt and strategically framed litigation before the administrative courts. For individual guidance on a medical residence permit application or refusal, consult our immigration law practice in Paris. The regime is demanding, but for those who meet its conditions, it provides a legally protected pathway to residence in France grounded in the right to health and human dignity.

📄 Official document

Our data comes from the Cour de cassation (Judilibre), the Conseil d'État, the DILA, the Court of Justice of the European Union and the European Court of Human Rights.

Recherche dans la base juridique

Retrouvez une décision, un texte ou une analyse

Plus de 100 000 décisions commentées par notre intelligence artificielle, indexées en temps réel.

    Recherche propulsée par Meilisearch sur kohenavocats.com.
    Étude préalable de dossier

    Envoyez vos pièces. Recevez une analyse.

    Transmettez-nous les pièces de votre dossier. Maître Hassan KOHEN les étudie personnellement et vous adresse une première analyse écrite de votre situation sous 24 heures ouvrées.

    • Analyse écrite de l'avocat, 80 € TTC
    • Réponse personnelle sous 24 heures ouvrées
    • 100 % confidentiel, secret professionnel garanti
    • Jusqu'à 1 Go de pièces au total, dossiers et sous-dossiers acceptés
    80 €TTC

    Étude préalable de votre dossier. Examen de vos pièces et première analyse écrite de Maître Hassan KOHEN, sous 24 heures ouvrées. Le règlement s'effectue en ligne après l'envoi de ce formulaire.

    Cliquez ou glissez vos fichiers ici
    Tous formats acceptés (PDF, Word, images, etc.)

    Envoi en cours...

    Le règlement vaut demande d'exécution immédiate de votre analyse. Vos données sont utilisées uniquement pour traiter votre demande.
    Conditions · Politique de confidentialité.

    IA juridique gratuite

    Une question de droit ? Demandez à Judith.

    Judith cherche dans les codes, la Constitution, la Convention européenne des droits de l’homme et les décisions des juges, puis vous montre les textes et les passages d’arrêts qui pourraient répondre à votre question, avec leur source officielle. Gratuite, sans compte, elle ne rédige rien à votre place. Découvrir Judith, l’IA juridique gratuite du cabinet.

    Trois recherches par jour, sans compte. Votre question est enregistrée et relue par le cabinet pour améliorer l’outil : n’y mettez ni nom ni information sensible.